Parasiticides — Revenue
Zoetis Parasiticides — Revenue increased by 8.1% to $586.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.3%, from $562.00M to $586.00M. Over 4 years (FY 2021 to FY 2025), Parasiticides — Revenue shows an upward trend with a 9.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests strong demand for preventative animal health care and successful market adoption of the product portfolio, while a decrease may indicate increased competition, patent expirations, or shifts in pet owner spending habits.
Detailed definition
This metric represents the total net sales generated from the sale of pharmaceutical products designed to prevent or tre...
Peer comparison
Comparable to animal health segments focused on preventative medicine or specialty pharmaceutical portfolios at major veterinary health competitors.
zts_segment_parasiticides_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $460.00M | $396.00M | $389.00M | $459.00M | $536.00M | $422.00M | $443.00M | $432.00M | $568.00M | $465.00M | $482.00M | $504.00M | $600.00M | $530.00M | $519.00M | $562.00M | $673.00M | $564.00M | $542.00M | $586.00M |
| QoQ Change | — | -13.9% | -1.8% | +18.0% | +16.8% | -21.3% | +5.0% | -2.5% | +31.5% | -18.1% | +3.7% | +4.6% | +19.0% | -11.7% | -2.1% | +8.3% | +19.8% | -16.2% | -3.9% | +8.1% |
| YoY Change | — | — | — | — | +16.5% | +6.6% | +13.9% | -5.9% | +6.0% | +10.2% | +8.8% | +16.7% | +5.6% | +14.0% | +7.7% | +11.5% | +12.2% | +6.4% | +4.4% | +4.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Zoetis's parasiticides — revenue?
- Zoetis (ZTS) reported parasiticides — revenue of $586.00M in Q1 2026.
- How has Zoetis's parasiticides — revenue changed year-over-year?
- Zoetis's parasiticides — revenue increased by 4.3% year-over-year, from $562.00M to $586.00M.
- What is the long-term trend for Zoetis's parasiticides — revenue?
- Over 4 years (2021 to 2025), Zoetis's parasiticides — revenue has grown at a 9.4% compound annual growth rate (CAGR), from $1.64B to $2.34B.
- What does parasiticides — revenue mean?
- Total revenue generated from the sale of animal parasite prevention and treatment products.